NSUN5通过增加SMAD3表达来促进肝细胞癌的进展
Hexu Han1, Chengcheng Zhang2, Wenbo Shi3
1Department of Gastroenterology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, 225300, P. R. China.
肝细胞癌 (HCC) 的进展是由NOP2/SunRNA甲基转移酶5 (NSUN5) 驱动的,它是一种促进转移的瘤基因. NSUN5通过调节基因组甲基化来促进表皮质-介质细胞过渡 (EMT),为HCC提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 肝细胞癌 (HCC) 经常转移,导致患者的治疗结果不佳.
- 表皮介质转变 (EMT) 是HCC转移的关键驱动因素.
- 在HCC和EMT中NOP2/SunRNA甲基转移酶5 (NSUN5) 的作用在很大程度上是未知的.
研究的目的:
- 为了研究肝细胞癌中NSUN5的表达和功能.
- 阐明NSUN5影响HCC转移和EMT的机制.
- 为了确定NSUN5是否在HCC中充当瘤基因.
主要方法:
- 多个HCC队列的临床病理学分析.
- 在Nsun5-Knockout小鼠中进行瘤形成研究.
- 在体外和体内测试评估细胞入侵和迁移.
- 涉及素甲基化 (H3K4me3) 和蛋白相互作用 (WDR5) 的机制研究.
主要成果:
- 在HCC瘤组织中,NSUN5的表达被上调.
- 缺乏Nsun5会阻碍HCC的进展,入侵和迁移.
- 过度表达NSUN5增强了EMT,入侵和迁移.
- NSUN5通过WDR5促进SMAD3促进器的H3K4me3丰富,驱动SMAD3介导的EMT.
结论:
- 在HCC中NSUN5的调节显著上升,并作为促进转移的瘤基因起作用.
- NSUN5通过SMAD3途径促进EMT,从而驱动HCC转移.
- NSUN5代表了对抗HCC转移的新型治疗标.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Induced Pluripotent Stem Cells
Somatic...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
